Deals Rumor Mill: Roche, JPMorgan, Goldman Sachs

Law360, New York (September 19, 2013, 2:19 PM ET) -- The top executive at Swiss drugmaker Roche Holding AG doused reports that his company was lining up financing for a BioMarin Pharmaceutical Inc. takeover play, according to a Thursday report from Bloomberg. DealReporter had suggested Roche was barreling toward a buyout offer for the California company, including seeking out $15 billion in funding to back its move. Roche CEO Severin Schwan played coy on the takeover talk, but said his company does not "have a need" to raise capital.

JPMorgan Chase & Co. is the likeliest...
To view the full article, register now.